01 January 2001
Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy
Igor Alexander Harsch, Eckhart Georg Hahn, Peter Christopher KonturekMed Sci Monit 2001; 7(4): CS751-754 :: ID: 421074
Abstract
BACKGROUND: H.pylori (H.p.) infection of the gastric mucosa is causallyrelated to chronic gastritis, peptic ulcer disease, MALT-lymphoma and gastric cancer. There is also anevidence for a link between the H.p.-infection and non-ulcer dyspepsia and even extragastric diseases.The number of patients treated against H.p. infection is expanding. Although in the last years the PPI-basedtriple therapies have been considered to be effective and safe, in some patients, however, severe side-effectsmay occur.
CASE REPORT: We report on a 86 year old female patient, who received a one-week triple eradicationtherapy (metronidazole 3x400 mg/die, clarithromycin 2x250 mg/die and omeprazole 2x20 mg/die) becauseof non-ulcer dyspepsia. A few days after the eradication treatment, she developed profuse watery andbloody diarrhea and abdominal pain with distention. In stool specimens Clostridium difficile toxin wasdetected. A colonoscopy showed typical features of antibiotic associated pseudomembranous colitis. Untilnow, only few reports concerning this complication have been published and the frequency of the complicationin patients eradicated for H.p. is unknown. The potential risk factors to develop this condition havenot been clarified. Since the complication may be potentially lethal, this severe side-effect of theusually well-tolerated triple-therapy has to be considered in patients suffering from profuse diarrheaand abdominal pain after eradication therapy.
Keywords: Helicobacter pylori, pseudomembranous colitis, clostridium difficile colitis, eradication
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
21 Mar 2024 : Meta-Analysis
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...Med Sci Monit In Press; DOI: 10.12659/MSM.943863
10 Apr 2024 : Clinical Research
Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...Med Sci Monit In Press; DOI: 10.12659/MSM.942612
06 Mar 2024 : Clinical Research
Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...Med Sci Monit In Press; DOI: 10.12659/MSM.941102
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952